APVO NASDAQ
Aptevo Therapeutics Inc.
1W: -5.8%
1M: -31.5%
3M: -60.2%
YTD: -81.0%
1Y: -92.9%
3Y: -100.0%
5Y: -100.0%
$1.76
+0.00 (+0.00%)
Weekly Expected Move ±7.3%
$2
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
12 relationships11
As Filer
counterparties named
1
As Counterparty
mentioned by others
2
Rel. Types
2021-11-05
Earliest Filing
2026-01-09
Latest Filing
partner: 9
investor: 2
Counterparties (Filed by APVO)
11 relationshipsCompanies named in APVO's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| YA II PN, LTD. | — | investor | Investor in a Standby Equity Purchase Agreement to purchase up to $60 million of common stock. | 2026-01-09 | View |
| Broadridge Corporate Issuer Solutions, LLC | — | partner | Rights Agent for the Rights Agreement | 2025-10-30 | View |
| Broadridge Financial Solutions, LLC | BR | partner | Rights Agent for the Rights Agreement | 2025-10-30 | View |
| Roth Capital Partners, LLC | — | partner | Placement agent for the securities offering. | 2025-06-20 | View |
| YA II PN, LTD. | — | investor | Investor in a Standby Equity Purchase Agreement with Aptevo Therapeutics Inc. | 2025-06-17 | View |
| Roth Capital Partners, LLC | — | partner | Sales agent for the At The Market Offering Agreement | 2025-04-28 | View |
| Broadridge Corporate Issuer Solutions, Inc. | — | partner | Rights Agent for the Rights Agreement | 2024-11-04 | View |
| Broadridge Financial Solutions, LLC. | BR | partner | Rights Agent for the Rights Agreement | 2024-11-04 | View |
| Broadridge Corporate Issuer Solutions, Inc. | — | partner | Rights Agent for the Rights Agreement | 2023-11-03 | View |
| HealthCare Royalty Management, LLC | — | partner | Entity managing the royalty purchase agreement for RUXIENCE residual royalty payments. | 2022-06-08 | View |
| Broadridge Corporate Issuer Solutions, Inc. | BRID | partner | Rights Agent for the Rights Agreement Amendment | 2021-11-05 | View |
Mentioned As Counterparty
1 mentionsOther companies that named APVO in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-24 | Other Events; Exhibits | View | |
| 2026-09-23 | Shareholder Vote | View | |
| 2026-09-03 | Other Events; Exhibits | View | |
| 2026-08-21 | Shareholder Vote | View | |
| 2026-08-14 | Earnings Release; Exhibits | View | |
| 2026-08-13 | Material Agreement; Unregistered Equity Sales; Other Events; Exhibits | Agreement | View |
| 2026-07-27 | Other Events; Exhibits | View | |
| 2026-06-30 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-05-27 | Material Agreement; Unregistered Equity Sales; Regulation FD; Exhibits | Agreement | View |
| 2026-05-13 | Earnings Release; Exhibits | View | |
| 2026-05-06 | Other Events; Exhibits | View | |
| 2026-03-26 | Earnings Release; Exhibits | View | |
| 2026-03-11 | Other Events; Financial Statements and Exhibits | View | |
| 2026-02-19 | Submission of Matters to a Vote of Security Holders | View | |
| 2026-02-03 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-01-09 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2025-12-29 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2025-12-09 | Financial Statements and Exhibits | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-30 | Entry into Material Definitive Agreement; Material Modification to Rights of Security Holders; Finan | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR